Navigation Links
Securities Class Action Filed by Shepherd, Finkelman, Miller & Shah, LLP on Behalf of Hemispherx Biopharma Securities Purchasers Between February 18, 2009 and November 2, 2009
Date:12/8/2009

you a copy of the Complaint.

The Complaint alleges that the Company violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder. Specifically, the Complaint alleges that, throughout the Class Period, the Company issued a series of materially false and misleading statements to the market concerning the status of its application for approval by the U.S. Food and Drug Administration ("FDA") of Ampligen, its experimental drug for the treatment of Chronic Fatigue Syndrome. While the market understood that the Company's application was complete and that any delays in FDA action were due to constraints on the FDA's resources, the Company took advantage of the inflated stock price to, among other things, raise millions of dollars in two public stock offerings.

On November 2, 2009, the Company announced that it still needed to submit additional information to the FDA, and revealed that it had already submitted six previously undisclosed reports to the FDA. As noted by market observers, this news stood in stark contrast to Class Period statements regarding the supposed status of Hemispherx's New Drug Application ("NDA"). As a result of this revelation, shares of Hemispherx's common stock closed at $1.33 per share on November 2, 2009, down $0.12 per share, and fell even more precipitously the next day, closing at $1.13 per share, well below the Class Period high of $3.75 per share reached on June 4, 2009. On December 1, 2009, Hemispherx announced that its NDA had been rejected by the FDA.

If you purchased Hemispherx securities between February 18, 2009 and November 2, 2009 (inclusive), you may qualify to serve as lead plaintiff on behalf of the Class. All motions for appointment as a lead plaintiff must be filed with the Court by no later than January 11, 2010. Any member of the proposed Class may move the Court to serve as lead plaintiff in this action through counsel of their choice, or ma
'/>"/>

SOURCE Shepherd, Finkelman, Miller & Shah, LLP
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. MICROS to Present at Wachovia Securities 1st Annual Services Conference
2. AHPC Holdings, Inc. Announces Intent to Deregister Common Stock With Securities and Exchange
3. Stryker Discloses Informal Inquiry Made by United States Securities and Exchange Commission
4. RxElite Files Registration Statement with Securities and Exchange Commission
5. Summary Notice of Class Action in Re McKesson HBOC, Inc. Securities Litigation
6. TorreyPines Therapeutics to Present at the JMP Securities Healthcare Focus Conference
7. Genomic Health to Present at JMP Securities Healthcare Focus Conference
8. Wolf Popper Announces Filing of Securities Class Action Lawsuit Against Medtronic Inc. - MDT
9. Cadence Pharmaceuticals Chief Medical Officer James Breitmeyer to Present at JMP Securities Healthcare Focus Conference
10. American Stock Exchange LLC to Delist Securities of AMS Health Sciences, Inc.
11. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at JMP Securities Sector Focus Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Airy Jeanine is a rising ... music video for her debut song “Mama’s Girl”, launched ... and abstract styling effects, the thematic video for the ... Vimeo, and assorted outlets. It will be integral in ... expanding full-scale marketing strategy. The video promotion campaign spearheaded ...
(Date:3/27/2015)... 27, 2015 April 2015 is the 150th ... Sesquicentennial. To honor America’s bloodiest war and the amazing President ... presents A Tribute to the Civil War and Abraham Lincoln. ... 17, 2015, at the Jane Pickens Theater in Newport, RI. ... scholar, will serve as the master of ceremonies. Dr. Fred ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 The Florida ... Accelerate Brain Cancer Cure (ABC2), awarded $350,000 to support ... of Florida, The Scripps Research Institute and H. Lee ... support studies with a clear development path and potential ... in the near future. , The awards fund ...
(Date:3/26/2015)... Houston, TX (PRWEB) March 27, 2015 ... is proud to announce prestigious victories at the 2015 ... The ranch was quite successful across many categories of ... of our performance at the ABBA International Brahman show,” ... enjoys friendly competition, and the proof of our superior ...
(Date:3/26/2015)... 26, 2015 Dr. Rod J. ... Dallas Rhinoplasty Symposium and has trained over 6500 ... importance of evidence based medicine (EBM), that is, the ... conducted research. , "We often hear from rhinoplasty ... while we are certainly not trying to stifle these ...
Breaking Medicine News(10 mins):Health News:Airy Jeanine Releases ‘’Mama’s Girl” Official Music Video 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 2Health News:The Florida Center for Brain Tumor Research and Accelerate Brain Cancer Cure Award $350,000 to Florida-Based Researchers 3Health News:Red and Gray Brahman Cattle Champions Announced by Moreno Ranches at International Brahman Show and Sale in Houston, Texas 2Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2
... News) -- People in lower Manhattan whose homes were damaged ... symptoms of respiratory diseases than those whose homes were not ... residents experienced some type of damage to their homes -- ... collapse of the World Trade Center,s Twin Towers. Previous ...
... from the U.S. Preventive Services Task Force (USPSTF) advising ... cancer in healthy men are likely to encounter serious ... a survey by Johns Hopkins investigators. In ... found that while doctors agreed with older recommendations to ...
... (SACRAMENTO, Calif.) UC Davis researchers have found that ... as it should be to cover the nation,s multi-billion ... almost 80 percent of these costs are paid by ... disability funds, employees and other payers. Authors ...
... , FRIDAY, May 25 (HealthDay News) -- Investigating indigenous ... or forager-horticulturist lifestyle is giving new insights into how ... Two new studies found that these types of ... pressure related to their age and are less likely ...
... May 25 (HealthDay News) -- Exposure to loud music at ... teenagers, researchers say. A small study by the ... reduced hearing after attending a three-hour show. This type of ... occurs repeatedly, permanent hearing loss can develop, the study authors ...
... in Spain during the first sexual encounter is similar to ... Spanish regions: women in Murcia use contraceptives less (55.8%) whereas ... SINC // , Spanish researchers have analysed ... over the last month in 5,141 sexually active women between ...
Cached Medicine News:Health News:People Who Lived Near World Trade Center Report More Lung Disease 2Health News:New prostate cancer screening guidelines face a tough sell, study suggests 2Health News:New prostate cancer screening guidelines face a tough sell, study suggests 3Health News:Most occupational injury and illness costs are paid by the government and private payers 2Health News:Amazon Tribe Gives Clues to Heart-Healthy Lifestyles 2Health News:Can Your Hear Me Now? 2Health News:70 percent of women use contraceptives during their first sexual encounter 2
(Date:3/27/2015)... According to a new market ... Advanced, Ultrasound), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices ... WPW) - Global Forecasts to 2019 ", published by MarketsandMarkets, ... ~$4.73 Billion by 2019 with a CAGR of around ... Browse   90   ma rket ...
(Date:3/27/2015)... , March 27, 2015 The International Myeloma ... myeloma patients while working toward prevention and a cure ... for introducing a federal resolution (H. Res. 174) that ... as "National Multiple Myeloma Awareness Month." Currently ... worldwide, and more than 110,000 new cases are diagnosed ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Electrophysiology (EP) Market Worth $4.73 Billion by 2019 2Electrophysiology (EP) Market Worth $4.73 Billion by 2019 3Electrophysiology (EP) Market Worth $4.73 Billion by 2019 4The International Myeloma Foundation (IMF) Secures the Introduction of a Federal Resolution Recognizing March 2015 as "National Multiple Myeloma Awareness Month" 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... new Mayo,Clinic study found that regular physical exercise ... of the brain that affects nerve cells,involved in ... the,American Academy of Neurology Annual Meeting in Chicago ... impairment can function reasonably well,in everyday activities, but ...
... IND Filing for Novavax,s ... Seasonal Influenza Vaccine Candidate, ROCKVILLE, Md., April 16 ... has received positive results from an,immunogenicity study in ferrets inoculated ... enable Novavax to,complete its planned investigational new drug ("IND") application ...
Cached Medicine Technology:Mayo Clinic Finds Exercise Can Reduce the Risk of Mild Cognitive Impairment 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 2Novavax Reports Positive Results from Preclinical Studies of its VLP-based Trivalent Seasonal Influenza Vaccine Candidate 3
Accu-Stat Home Drug Test for Marijuana (THC), Cocaine (COC), Amphetamine (AMP), Methamphetamine (mAMP), Opiates (OPI), and Phencyclidine (PCP)....
... SEDIPLAST® is a completely closed system ... laboratory personnel from the risk associated ... uniquely designed erythrocyte sedimentation rate test ... convenience as well as reliable and ...
... Unlike other ESR products, SEDIPLAST® is ... design features to protect laboratory personnel ... handling. SEDIPLAST® is a uniquely designed ... provides greater safety and convenience as ...
... The use of guaiac as ... of blood is based on ... present in guaiac to quinones, ... a blue color. If blood ...
Medicine Products: